Liver Enzymes and Uric acid in Acute Heart Failure. 2015

Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
Preventive Atherosclerotic Research Center, Cardiology Department, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran.

BACKGROUND Acute heart failure (AHF) is defined as the new onset or recurrence of gradual or rapidly worsening signs and symptoms of heart failure, requiring urgent or emergent therapy. OBJECTIVE This study attempts to assess the association of liver function tests (LFT) and uric acid level with in hospital outcome and echocardiography parameters, in patients with acute decompensated heart failure. METHODS A total of 100 patients (aged 16 - 90 years, 60% men) admitted with AHF were enrolled. LFTs and uric acid levels were assessed on first day and before discharge, and patients were followed for 3 months. RESULTS In-hospital outcomes were considered. Mean Left Ventricular Ejection Fraction (LVEF) was 35% (20 - 45%). Mean Uric acid level was 8.4 mg/dL, significantly higher than chronic HF and normal groups (P < 0.02). Elevated liver enzymes were seen in 52% patients, mostly (87%) in transaminases. Liver enzymes were decreased in 85% patients before discharge. LFT and uric acid levels were inversely and significantly correlated with LVEF on echocardiography (P = 0.02), but not with diastolic parameters. Although there was no significant correlation between uric acid level and in-hospital mortality, risk of intubation and rehospitalization in 3 months, enzyme levels increased in these groups. Increased aspartate transaminase (AST level) was associated with inotrope infusion in AHF patients (42 vs. 82 mg/dL, P = 0.03). CONCLUSIONS Abnormal transaminases and uric acid levels are seen in AHF patients. Increased AST levels may be a predictor of the need for inotrope during hospital course in these patients.

UI MeSH Term Description Entries

Related Publications

Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
January 2005, Seminars in nephrology,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
May 2022, European journal of internal medicine,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
November 2003, Circulation,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
December 2012, Journal of critical care,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
September 2021, Terapevticheskii arkhiv,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
July 2012, The open biomarkers journal,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
April 2011, Revista medica de Chile,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
December 2008, European journal of heart failure,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
November 2006, Archives of internal medicine,
Farveh Vakilian, and Abbas Ali Rafighdoost, and Amir Hossein Rafighdoost, and Ahmad Amin, and Maryam Salehi
December 2008, European journal of heart failure,
Copied contents to your clipboard!